![](https://webarchive.library.unt.edu/eot2008/20081104172103im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081104172103im_/http://www.cancer.gov/images/spacer.gif)
| A substance being studied in the treatment of some types of leukemia and lymphoma. It is a type of purine nucleoside phosphorylase (PNP) inhibitor. Also called forodesine and forodesine hydrochloride. |
Previous Definitions: | BCG, BCG solution, bcl-2 antisense oligodeoxynucleotide G3139, BCL2, BCR-ABL fusion gene | Next Definitions: | BDC, Beckwith-Wiedemann syndrome, beclin 1, beclomethasone, behavior modification |
|
![](https://webarchive.library.unt.edu/eot2008/20081104172103im_/http://www.cancer.gov/images/spacer.gif) |